In Silico Approach for Immunohistochemical Evaluation of a Cytoplasmic Marker in Breast Cancer

Cancers - Switzerland
doi 10.3390/cancers10120517
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Immunohistochemical Evaluation of Β-Catenin Marker in Papillary Thyroid Cancer Clinicopathologic Behavior

2018English

The Value of Cytoplasmic Y-Box-Binding Protein 1 as a Prognostic Marker for Breast Cancer in Korean

Breast Cancer
Nuclear MedicineRadiologyPharmacologyOncologyImagingMedicine
2015English

Tetraploidy: A New Marker for Breast Cancer?

Journal of Carcinogenesis & Mutagenesis
2013English

Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study

European Journal of Breast Health
2018English

Identification of Breast Cancer Neoantigens Using in Silico Methodologies

2019English

The Role of Oestrogen and Progesterone Receptors in Breast Cancer – Immunohistochemical Evaluation of Oestrogen and Progesterone Receptor Expression in Invasive Breast Cancer in Women

Wspolczesna Onkologia
OncologyRadiologyNuclear MedicineImaging
2015English

AKT1 - A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer

2004English

S100β as a Serum Marker in Endocrine Resistant Breast Cancer

BMC Medicine
Medicine
2017English

Immunohistochemical Study of the Distribution of Estradiol in Breast Cancer

The journal of the Japanese Practical Surgeon Society
1989English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy